表紙
市場調査レポート

世界の性行為感染症(STD)検査市場:新たな検査方法、技術評価、装置の分析、市場シェア、国別の売上高予測、主要サプライヤーの戦略的プロファイル

2016-2020 Future Horizons and Growth Strategies in the World Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Opportunities

発行 Venture Planning Group 商品コード 263192
出版日 ページ情報 英文 350 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。

Local License: 同一事業所内

Back to Top
世界の性行為感染症(STD)検査市場:新たな検査方法、技術評価、装置の分析、市場シェア、国別の売上高予測、主要サプライヤーの戦略的プロファイル 2016-2020 Future Horizons and Growth Strategies in the World Sexually-Transmitted Diseases (STD) Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Opportunities
出版日: ページ情報: 英文 350 Pages
概要

当レポートでは、全世界の性行為感染症(STD)検査の関連市場について分析し、研究開発の最新動向と将来展望、世界の主要国(計7ヶ国)の市場動向の予測(主要サプライヤーの市場収益・シェアなど)、市場のリスク、主な製品開発機会、主要企業のプロファイルといった情報を盛り込んで、概略以下の構成でお届けします。

イントロダクション

世界の市場・技術の概要

  • 主な感染症の検査(背景事情、診断検査、ワクチン・薬剤)
    • 軟性下疳
    • クラミジア
    • 淋病
    • 単純ヘルペスウイルス
    • ヒトヘルペスウイルス6型(HHV-6)
    • パピローマウイルス(HPV)
    • 梅毒
  • 代表的な解析装置のレビュー(発売元:Abbott、Beckman Coulter/Danaher、BioMerieux、Ortho-Clinical Diagnostics、Roche、Siemens、東ソー、Wallacほか)
  • 新規の診断技術
    • 分子診断
    • モノクローナル抗体
    • 免疫学的検定
    • 差分光散乱
    • 情報技術(IT)
    • 人工知能
    • リポソーム
    • フローサイトメトリ
    • クロマトグラフィ
    • 画像診断
    • ゲル微液滴
    • その他

フランス市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

ドイツ市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

イタリア市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

日本市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

スペイン市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

英国市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

米国市場:市場規模・成長率、主要サプライヤーの売上高と市場シェア

代替的な市場普及戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 分散型検査市場の流通戦略
    • マーケティングのアプローチ
    • 製品の複雑性
    • 顧客の選好
    • 既存のサプライヤー
    • 新規参入サプライヤー
    • 流通業者の主な種類
    • 市場の分類

潜在的な市場参入障壁とリスク

  • 市場の成熟化
  • コスト抑制
  • 競争
  • 最先端技術とその限界
  • 特許保護
  • 規制による抑制
  • 分散型検査市場の課題

競合企業分析

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • 栄研化学
  • Enzo Biochem
  • 富士レビオ
  • Gen-Probe
  • Hologic
  • ID Biomedical
  • Innogenetics/Solvay
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • タカラバイオ
  • Thermo Fisher
  • Wallac
  • 和光純薬

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPID17707

This new 350-page report from VPGMarketResearch.com contains 90 tables and provides analysis of the global sexually-transmitted disease testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.

The report presents detailed analysis of the STD market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on epidemiology and etiology are presented for Chancroid, Chlamydia, Gonorrhea, Herpes (I/II, VI), Papillomavirus (Pap Smear, HPV), and Syphilis. The report provides test volume and sales forecasts by country and market segment, including:

     - Hospitals
     - Commercial/Private Labs
     - Physician Offices
     - Public Health Labs      

In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of STD diagnostic products, by test and country.  Also, the report:

     -  Examines market applications of Molecular Diagnostics,  
        Monoclonal Antibodies, Immunoassays, IT and other emerging technologies;

     -  Reviews features and operating characteristics of major analyzers used 
        for STD testing;

     -  Profiles key suppliers and potential market entrants developing innovative
        technologies and products; and

     -  Analyzes emerging opportunities, alternative market penetration strategies, 
         market entry barriers/risks, and strategic planning issues.

Methodology

The report is based on a combination of primary and secondary information sources, including interviews with laboratory directors, and executives of leading diagnostics companies and start-up firms developing innovative products in the U.S., five major European countries and Japan.

In addition to primary sources of information, a comprehensive review of the most recent technical and business publications, manufacturer product and financial literature, as well as VPGMarketResearch’s proprietary data files was conducted.
 
Contains: 350 pages and 90 tables

Table of Contents

I. Introduction

II. Worldwide Market and Technology Overview

  • A. Major Infectious Disease Tests
    • 1. Chancroid
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 2. Chlamydia
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 3. Gonorrhea
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 4. Herpes Simplex Virus
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • Human Herpes Virus-6 (HHV-6)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 5. Papillomavirus (HPV)
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
    • 6. Syphilis
      • a. Background
      • b. Diagnostic Tests
      • c. Vaccines and Drugs
  • B. Instrumentation Review of Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, BioMerieux, Ortho-Clinical Diagnostics, Roche, Siemens, Tosoh, Wallac and Other Suppliers
  • C. Emerging Diagnostic Technologies
    • 1. Molecular Diagnostics
    • 2. Monoclonal Antibodies
    • 3. Immunoassays
    • 4. Differential Light Scattering
    • 5. Information Technology
    • 6. Artificial Intelligence
    • 7. Liposomes
    • 8. Flow Cytometry
    • 9. Chromatography
    • 10. Diagnostic Imaging
    • 11. Gel Microdroplets
    • 12. Other

III. France: Market Size, Growth and Major Suppliers' Sales and Market Shares

IV. Germany: Market Size, Growth and Major Suppliers' Sales and Market Shares

V. Italy: Market Size, Growth and Major Suppliers' Sales and Market Shares

VI. Japan: Market Size, Growth and Major Suppliers' Sales and Market Shares

VII. Spain: Market Size, Growth and Major Suppliers' Sales and Market Shares

VIII. UK: Market Size, Growth and Major Suppliers' Sales and Market Shares

IX. USA: Market Size, Growth and Major Suppliers' Sales and Market Shares

Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies for Decentralized Testing Markets
    • 1. Marketing Approaches
    • 2. Product Complexity
    • 3. Customer Preference
    • 4. Established Suppliers
    • 5. Emerging Suppliers
    • 6. Major Types of Distributors
    • 7. Market Segmentation

Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

Competitive Assessments

  • Abbott
  • Affymetrix
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • bioMerieux
  • Bio-Rad
  • Cepheid
  • Diamedix
  • DiaSorin
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Hologic/Gen-Probe
  • ID Biomedical/GSK
  • Kreatech
  • Life Technology
  • Lonza
  • Nanogen/Elitech
  • Novartis Diagnostics
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Roche
  • Scienion
  • Sequenom
  • SeraCare
  • Siemens
  • Takara Bio
  • Thermo Fisher
  • Wallac/PE
  • Wako

List of Tables

  • Major Companies Developing or Marketing Chlamydia Tests
  • Major Companies Developing or Marketing Gonorrhea Tests
  • Major Companies Developing or Marketing Herpes Tests
  • Major Companies Developing or Marketing Pap Smear/HPV Tests
  • Major Companies Developing or Marketing Syphilis Tests
  • France
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Chlamydia Diagnostics Sales by Major Supplier
  • France
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • France
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • France
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • France
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Germany
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Italy
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Chlamydia Diagnostics Sales by Major Supplier
  • Japan
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Japan
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Japan
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • Spain
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Chlamydia Diagnostics Sales by Major Supplier
  • Spain
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • Spain
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.K.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chancroid Diagnostics Sales by Major Supplier
  • U.S.A.
  • Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Chlamydia Diagnostics Sales by Major Supplier
  • U.S.A.
  • Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Gonorrhea Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Herpes Testing Market Diagnostics Sales by Major Supplier
  • U.S.A.
  • PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Papillomavirus (HPV) Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.S.A.
  • Syphilis Testing Market Diagnostics Sales by Major Supplier
Back to Top